Differential stress-induced ischemic electrocardiographic changes in acute versus stable coronary syndromes with severely reduced fractional flow reserve (≤0.60) Authors: Do-Yoon Kang, Ji Sung Lee, Cheol Whan Lee Published: 2026 ABSTRACT BackgroundFractional flow reserve (FFR) is widely used to guide percutaneous coronary intervention (PCI) as a surrogate of inducible myocardial ischemia (IMI). However, the relationship between very low FFR, electrically manifest ischemia, and subsequent symptomatic benefit remains incompletely understood.MethodsWe investigated stress-induced ischemic electrocardiographic changes in 79 patients with FFR ≤ 0.60, comparing acute coronary syndrome (ACS) and stable coronary artery disease (CAD), and its association with post-PCI symptom improvement. IMI was defined by ischemic ST-segment changes during adenosine stress testing. Pressure-derived physiologic indices, including the instantaneous wave-free ratio (iFR) and resting Pd/Pa, were measured, and angina-related symptoms were assessed using the Seattle Angina Questionnaire.ResultsIMI was present in all patients with ACS but was absent in 40 % of patients with stable CAD (p < 0.001). Despite similar angiographic severity and mean FFR values, iFR and resting Pd/Pa were significantly lower in ACS. In multivariate analyses, ACS and lower iFR or resting Pd/Pa independently predicted IMI. Although angina symptoms improved overall after PCI, the greatest improvement occurred in patients with ACS or IMI.ConclusionsAt extremely low FFR values (≤0.60), substantial discordance exists between pressure-derived physiology and IMI, which is closely related to clinical presentation and symptomatic benefit after PCI. Introduction Fractional flow reserve (FFR) is widely used to guide percutaneous coronary intervention (PCI) as a surrogate marker of inducible myocardial ischemia. However, a low FFR does not uniformly translate into objective ischemic manifestations or clinical benefit after revascularization [1], [2]. Indeed, a subset of patients with very low FFR values fails to demonstrate ischemic electrocardiographic changes during stress testing and derives limited symptomatic improvement after PCI. Stress-induced electrical manifestations, as reflected by ischemic electrocardiographic changes, provide more direct evidence of myocardial ischemia than pressure-derived indices alone and may be modulated by underlying pathophysiologic differences between acute and chronic coronary syndromes. Despite this, data comparing stress-induced electrical responses according to clinical presentation remain limited. Therefore, in the present study, we investigated stress-induced ischemic electrocardiographic changes in patients with FFR ≤ 0.60, comparing those with acute coronary syndrome (ACS) and stable coronary artery disease (CAD), and examined its association with symptomatic improvement following PCI. Materials and methods Study population Detailed methods have been described previously [3]. Briefly, patients with angiographically significant CAD, defined as a visually assessed diameter stenosis ≥ 50 %, were eligible for inclusion in the study. Key exclusion criteria included ST-segment elevation acute myocardial infarction, prior coronary artery bypass graft surgery, abnormal baseline echocardiographic or electrocardiographic findings, known contraindications to adenosine administration, and the presence of multivessel CAD. Study protocols The study protocol was approved by the institutional review board, and all participants provided written informed consent prior to enrollment. Coronary angiographies were performed within 24–72 h of emergency department presentation in patients with ACS and after elective admission in those with stable CAD. Measurements were performed in the culprit vessel, and all cases involved single-vessel severe CAD. During the procedure, a pressure wire was advanced and positioned distal to the target lesion. Resting whole-cycle distal-to-aortic coronary pressure ratio (Pd/Pa) and instantaneous wave-free ratio (iFR) were then measured under stable baseline conditions. Thereafter, intravenous adenosine was administered via a large antecubital vein at an infusion rate of 140 µg/kg per minute for 3 min, followed by an increased dose of 200 µg/kg per minute for an additional 3 min [4], to ensure maximal hyperemia (Fig. 1). FFR was continuously recorded throughout adenosine infusion, and both the nadir (FFRn) and the most stable (FFRs) values were documented for analysis. A standard 12-lead electrocardiogram was continuously monitored during adenosine administration and formally recorded at baseline and at the completion of each infusion stage to assess stress-induced electrical changes. Immediately after completion of FFR assessment, PCI was performed using standard contemporary techniques [5]. Offline quantitative coronary angiographic analysis was subsequently conducted using a validated software platform (CAAS workstation version 7.4; Pie Medical Imaging, Maastricht, the Netherlands). Electrocardiography interpretation was performed with blinding to the FFR data to minimize potential bias. Two experienced reviewers independently evaluated the electrocardiographys and reached a final decision by consensus.Fig. 1Study protocol of adenosine-induced ECG assessment and FFR measurement. ECG, electrocardiography; FFR, fractional flow reserve. Study protocol of adenosine-induced ECG assessment and FFR measurement. ECG, electrocardiography; FFR, fractional flow reserve. Definitions ACS was defined as progressive angina or resting chest pain leading to presentation to the emergency department, including unstable angina and non-ST-segment elevation myocardial infarction. ACS patients had normal baseline electrocardiographic and echocardiographic findings without evidence of ischemia or regional wall motion abnormalities. Non-ST-segment elevation myocardial infarction was defined by elevated high-sensitivity troponin I above the diagnostic threshold with normal creatine kinase-MB levels, indicating minimal myocardial injury. Definite inducible myocardial ischemia was defined as the development of new ST elevation (>0.1 mV) or depression (horizontal or down-sloping) compared to baseline in at least 2 consecutive leads during adenosine infusion. Angina severity was assessed using the 7-item Seattle Angina Questionnaire (SAQ) at baseline and 1 month after PCI [6]. Statistical analysis Categorical variables are presented as percentages and were compared using the chi-square or Fisher’s exact test. Continuous variables are expressed as mean ± standard deviation and were compared using Student’s t-test. Univariate logistic regression analyses were used to identify predictors of inducible myocardial ischemia, with results reported as odds ratios (ORs) and 95 % confidence intervals (CIs); variables significant in univariate analyses were entered into multivariate models. Changes in angina-related symptoms after PCI were assessed using differences in SAQ summary scores and compared between groups using Student’s t-test. All analyses were performed using SAS software, version 9.4, with two-sided p values < 0.05 considered statistically significant. Results Of the 227 patients who completed the study, 79 met the predefined criterion of an FFR nadir ≤ 0.60, which was selected to represent an extreme range of physiological severity based on prior studies [7], [8]. The study population consisted of 22 patients with ACS, including 16 with unstable angina and 6 with non-ST-segment elevation myocardial infarction, and 57 patients with stable CAD. Culprit lesions were located in the left main artery in 2 patients and in the left anterior descending artery in 77 patients, and all lesions were treated with PCI following the adenosine stress test. Definite inducible myocardial ischemia was observed in all patients with ACS and in 59.6 % of those with stable CAD, demonstrating a significant difference between the two groups (p < 0.001). Baseline characteristics were largely comparable between the two groups, including the degree of diameter stenosis and mean FFR values (Table 1). In contrast, physiologic indices reflecting resting coronary hemodynamics differed between groups, with significantly lower iFR and resting Pd/Pa values observed in patients with ACS compared with those with stable CAD. In univariate logistic regression analyses, ACS (OR, 30.66; 95 % CI, 1.66–565.07; p = 0.021), hemoglobin concentration (OR, 0.62; 95 % CI, 0.43–0.89; p = 0.009), iFR (OR, 1.06 per 0.01-unit decrease; 95 % CI, 1.03–1.09; p < 0.001), resting Pd/Pa (OR, 1.07 per 0.01-unit decrease; 95 % CI, 1.03–1.11; p = 0.001), and active smoking at the time of index hospitalization (OR, 0.30; 95 % CI, 0.10–0.89; p = 0.031) were identified as significant predictors of inducible myocardial ischemia (Table 2). Given the presence of multicollinearity among pressure-derived physiologic indices, as indicated by variance inflation factors greater than 10, multivariate logistic regression analyses were performed separately for each index in combination with other covariates. In these models, ACS (OR, 21.22; 95 % CI, 1.13–398.83; p = 0.041) and iFR (OR, 1.04 per 0.01-unit decrease; 95 % CI, 1.01–1.08; p = 0.011), as well as ACS (OR, 18.94; 95 % CI, 1.06–337.33; p = 0.045) and resting Pd/Pa (OR, 1.05 per 0.01-unit decrease; 95 % CI, 1.01–1.09; p = 0.022), emerged as independent predictors of inducible myocardial ischemia. Consistent with these findings, SAQ scores showed significant improvement after PCI. The magnitude of symptomatic improvement was greater in patients with ACS than in those with stable CAD (ΔSAQ summary score: 32.69 ± 21.97 vs. 10.48 ± 18.91; p < 0.001) and was also more pronounced in patients with inducible myocardial ischemia compared with those without inducible ischemia (ΔSAQ summary score: 21.50 ± 20.48 vs. 5.37 ± 21.56; p = 0.003).Table 1Baseline characteristics.ACS (n = 22)Stable CAD (n = 57)Age, years63.9 ± 9.964.2 ± 8.0 SexMale16 (72.7 %)50 (87.7 %)Female6 (27.3 %)7 (12.3 %) Risk factorsCurrent smoker4 (18.2 %)14 (24.6 %)Diabetes mellitus5 (22.7 %)12 (21.1 %)Hypertension11 (50 %)21 (36.8%) Laboratory findingsHemoglobin (g/dl)13.5 ± 1.614.1 ± 1.7LDL cholesterol (mg/dl)103.9 ± 51.2104.2 ± 46.0HDL cholesterol (mg/dl)47.2 ± 12.649.5 ± 14.0Triglyceride (mg/dl)115.3 ± 55.0141.6 ± 82.6Left ventricular ejection fraction (%)63.0 ± 3.163.8 ± 4.2Diameter stenosis by QCA (%)73.9 ± 21.275.9 ± 12.0 Physiologic indicesHeart rate (beats/min)81.7 ± 11.883.4 ± 14.0Systolic blood pressure (mmHg)106.0 ± 23.1109.4 ± 20.3Diastolic blood pressure (mmHg)54.3 ± 11.756.4 ± 9.8Resting Pd/Pa*0.56 ± 0.170.67 ± 0.17iFR**0.40 ± 0.180.52 ± 0.21FFRn0.44 ± 0.120.47 ± 0.09FFRs0.50 ± 0.130.52 ± 0.09ACS, acute coronary syndrome; CAD, coronary artery disease; FFRn, fractional flow reserve at its lowest value; FFRs, fractional flow reserve in a stable status; HDL, high-density lipoprotein; iFR, instantaneous wave-free ratio; LDL, low-density lipoprotein; QCA, quantitative coronary angiography; rPd/Pa, resting whole-cycle distal-to-aortic coronary pressure ratio. Heart rate and blood pressure were measured in a stable state during the adenosine stress test. *P value = 0.013, **P value = 0.016.Table 2Predictors of inducible myocardial ischemia.ParametersUnivariate OR (95 % CI)P valueMultivariate (1) OR (95 % CI)P valueMultivariate (2) OR (95 % CI)P valueACS (vs. Stable CAD)30.66 (1.66–565.07)0.02118.94 (1.06–337.33)0.04521.22 (1.13–398.83)0.041rPd/Pa (per 0.01 unit decrease)1.07 (1.03–1.11)0.0011.05 (1.01–1.09)0.022iFR (per 0.01 unit decrease)1.06 (1.03–1.09)<0.0011.04 (1.01–1.08)0.011Current smoker0.30 (0.10–0.89)0.0310.26 (0.06–1.03)0.0550.25 (0.06–1.03)0.054Hemoglobin (g/dl)0.62 (0.43–0.89)0.0090.76 (0.49–1.17)0.2110.82 (0.53–1.27)0.371DS by QCA (per 10 % increase)1.00 (0.97–1.03)0.932FFRn (per 0.01 unit decrease)1.05 (0.99–1.10)0.107FFRs (per 0.01 unit decrease)1.04 (0.98–1.09)0.196ACS, acute coronary syndrome; CAD, coronary artery disease; CI, confidence interval; DS by QCA, diameter stenosis by quantitative coronary angiography; FFRn, fractional flow reserve at its lowest value; FFRs, fractional flow reserve in a stable status; iFR, instantaneous wave-free ratio; rPd/Pa, resting whole-cycle distal-to-aortic coronary pressure ratio; OR, odd ratio. Table 1Baseline characteristics.ACS (n = 22)Stable CAD (n = 57)Age, years63.9 ± 9.964.2 ± 8.0 SexMale16 (72.7 %)50 (87.7 %)Female6 (27.3 %)7 (12.3 %) Risk factorsCurrent smoker4 (18.2 %)14 (24.6 %)Diabetes mellitus5 (22.7 %)12 (21.1 %)Hypertension11 (50 %)21 (36.8%) Laboratory findingsHemoglobin (g/dl)13.5 ± 1.614.1 ± 1.7LDL cholesterol (mg/dl)103.9 ± 51.2104.2 ± 46.0HDL cholesterol (mg/dl)47.2 ± 12.649.5 ± 14.0Triglyceride (mg/dl)115.3 ± 55.0141.6 ± 82.6Left ventricular ejection fraction (%)63.0 ± 3.163.8 ± 4.2Diameter stenosis by QCA (%)73.9 ± 21.275.9 ± 12.0 Physiologic indicesHeart rate (beats/min)81.7 ± 11.883.4 ± 14.0Systolic blood pressure (mmHg)106.0 ± 23.1109.4 ± 20.3Diastolic blood pressure (mmHg)54.3 ± 11.756.4 ± 9.8Resting Pd/Pa*0.56 ± 0.170.67 ± 0.17iFR**0.40 ± 0.180.52 ± 0.21FFRn0.44 ± 0.120.47 ± 0.09FFRs0.50 ± 0.130.52 ± 0.09ACS, acute coronary syndrome; CAD, coronary artery disease; FFRn, fractional flow reserve at its lowest value; FFRs, fractional flow reserve in a stable status; HDL, high-density lipoprotein; iFR, instantaneous wave-free ratio; LDL, low-density lipoprotein; QCA, quantitative coronary angiography; rPd/Pa, resting whole-cycle distal-to-aortic coronary pressure ratio. Heart rate and blood pressure were measured in a stable state during the adenosine stress test. *P value = 0.013, **P value = 0.016. Baseline characteristics. ACS, acute coronary syndrome; CAD, coronary artery disease; FFRn, fractional flow reserve at its lowest value; FFRs, fractional flow reserve in a stable status; HDL, high-density lipoprotein; iFR, instantaneous wave-free ratio; LDL, low-density lipoprotein; QCA, quantitative coronary angiography; rPd/Pa, resting whole-cycle distal-to-aortic coronary pressure ratio. Heart rate and blood pressure were measured in a stable state during the adenosine stress test. *P value = 0.013, **P value = 0.016. Table 2Predictors of inducible myocardial ischemia.ParametersUnivariate OR (95 % CI)P valueMultivariate (1) OR (95 % CI)P valueMultivariate (2) OR (95 % CI)P valueACS (vs. Stable CAD)30.66 (1.66–565.07)0.02118.94 (1.06–337.33)0.04521.22 (1.13–398.83)0.041rPd/Pa (per 0.01 unit decrease)1.07 (1.03–1.11)0.0011.05 (1.01–1.09)0.022iFR (per 0.01 unit decrease)1.06 (1.03–1.09)<0.0011.04 (1.01–1.08)0.011Current smoker0.30 (0.10–0.89)0.0310.26 (0.06–1.03)0.0550.25 (0.06–1.03)0.054Hemoglobin (g/dl)0.62 (0.43–0.89)0.0090.76 (0.49–1.17)0.2110.82 (0.53–1.27)0.371DS by QCA (per 10 % increase)1.00 (0.97–1.03)0.932FFRn (per 0.01 unit decrease)1.05 (0.99–1.10)0.107FFRs (per 0.01 unit decrease)1.04 (0.98–1.09)0.196ACS, acute coronary syndrome; CAD, coronary artery disease; CI, confidence interval; DS by QCA, diameter stenosis by quantitative coronary angiography; FFRn, fractional flow reserve at its lowest value; FFRs, fractional flow reserve in a stable status; iFR, instantaneous wave-free ratio; rPd/Pa, resting whole-cycle distal-to-aortic coronary pressure ratio; OR, odd ratio. Predictors of inducible myocardial ischemia. ACS, acute coronary syndrome; CAD, coronary artery disease; CI, confidence interval; DS by QCA, diameter stenosis by quantitative coronary angiography; FFRn, fractional flow reserve at its lowest value; FFRs, fractional flow reserve in a stable status; iFR, instantaneous wave-free ratio; rPd/Pa, resting whole-cycle distal-to-aortic coronary pressure ratio; OR, odd ratio. Discussion Our study demonstrates a significant discrepancy between pressure-derived FFR and direct evidence of inducible myocardial ischemia according to clinical presentation in patients with extremely low FFR (≤ 0.60). While all patients with ACS exhibited inducible myocardial ischemia, approximately 40 % of patients with stable CAD did not, despite identical FFR nadirs. These findings indicate that, in patients with very low FFR, “functional” significance is not merely numerical but reflects the interplay between acute stress and physiological adaptation, with adaptive physiological factors serving as critical determinants of overt myocardial ischemia. This phenomenon may be explained by myocardial adaptation and differences in residual coronary flow reserve. In patients with stable CAD, chronic exposure to repetitive and subcritical ischemic episodes promotes myocardial adaptation through the activation of endogenous cardioprotective mechanisms, including ischemic preconditioning, metabolic downregulation, and enhanced tolerance to hypoxic stress. These adaptive processes raise the electrical ischemic threshold, thereby attenuating stress-induced electrocardiographic manifestations despite the presence of anatomically or physiologically significant epicardial stenosis [9]. In contrast, ACS is characterized by an abrupt deterioration in coronary hemodynamics, often due to plaque rupture or thrombosis, which occurs without sufficient time for compensatory myocardial adaptation. As a result, the myocardium in ACS remains highly vulnerable to ischemic stress, leading to a uniformly high incidence of objective ischemic manifestations during stress testing. Furthermore, the significantly lower iFR and resting Pd/Pa observed in patients with ACS suggest a more severely exhausted resting coronary flow reserve and a higher degree of microvascular dysfunction compared with patients with stable CAD [10]. These findings imply that both epicardial and microvascular components contribute to the heightened ischemic susceptibility in ACS. In addition, the associations of hemoglobin concentration and smoking status with inducible myocardial ischemia in univariate analyses support the concept that systemic oxygen-carrying capacity and chronic ischemic preconditioning may modulate the myocardial response to acute stress. Higher hemoglobin levels may enhance oxygen delivery under stress conditions, while chronic exposure to smoking-related hypoxia may trigger adaptive mechanisms, including upregulation of hypoxia-inducible pathways and improved ischemic tolerance. This phenomenon has been described as the “smoker’s paradox,” in which smokers appear to exhibit attenuated ischemic manifestations under certain conditions [11]. Such adaptations may, at least in part, resemble a form of chronic preconditioning, potentially leading to a blunted electrocardiographic response to acute ischemia. However, this interpretation should be made with caution, as the “smoker’s paradox” remains controversial. Together, these factors may partially explain the observed heterogeneity in ischemic manifestations among patients with similarly reduced FFR values. Finally, the magnitude of symptomatic improvement was greater in patients with ACS than in those with stable CAD, and in those with inducible myocardial ischemia than in those without. However, these findings should be interpreted with caution. Baseline SAQ scores in ACS may be influenced by the acute presentation, potentially exaggerating the apparent magnitude of improvement, and symptom relief after PCI may also be affected by procedural success and adjunctive pharmacotherapy. Consistent with prior evidence, including the ORBITA-2 trial [12], the present study was designed to assess early symptomatic response rather than long-term outcomes. Although inducible ischemia may help identify patients more likely to experience symptomatic benefit after PCI, further studies are needed to evaluate long-term outcomes. Limitations To minimize potential variability arising from measurements obtained at different time points, electrocardiographic changes were monitored simultaneously and used as the reference for assessing inducible myocardial ischemia during FFR measurement. While this approach ensured temporal consistency between physiological and electrical assessments, several limitations should be acknowledged. First, the generalizability of our findings may be limited by both anatomical and methodological considerations. This study was restricted to the left main and left anterior descending arteries to minimize the influence of gravitational potential energy on pressure-derived physiological indices [13]. Consequently, the applicability of these results to right coronary or left circumflex artery disease remains uncertain. In addition, the use of adenosine-induced ST-segment changes as the sole marker of inducible ischemia may be limited, particularly in non-anterior territories where the sensitivity of ST-segment changes is known to be lower. Second, echocardiographic monitoring was not performed during cardiac catheterization because of technical challenges associated with image acquisition in the supine position. As a result, direct assessment of stress-induced regional wall motion abnormalities was not possible, limiting mechanistic insight into the relationship between physiological ischemia and myocardial contractile response. Furthermore, coronary flow reserve, microvascular resistance, and biomarkers of ischemic adaptation were not assessed. Therefore, the mechanistic hypotheses proposed to explain our findings remain speculative. Third, the wide confidence interval for the odds ratio of ACS may be attributable to the small sample size and quasi-complete separation. Although Firth’s penalized logistic regression was applied to mitigate this issue, the results should be interpreted with caution. Fourth, further studies incorporating comprehensive physiological measurements and multimodality imaging are needed to clarify the mechanisms underlying the differential patterns of stress-induced ischemic electrocardiographic changes observed between ACS and stable CAD in patients with severely reduced FFR (≤0.60). Conclusion At extremely low FFR values (≤0.60), substantial discordance exists between pressure-derived physiology and inducible myocardial ischemia, which is closely related to clinical presentation and symptomatic benefit after PCI. This discordance is more frequently observed in stable CAD than in ACS. Statement of authorship: This author takes responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. CRediT authorship contribution statement Do-Yoon Kang: Writing – original draft, Methodology, Investigation. Ji Sung Lee: Formal analysis, Data curation. Cheol Whan Lee: Writing – review & editing, Validation, Project administration, Methodology, Investigation, Conceptualization. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.